Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Loratadine Orally Disintegrating Tablets

Approval Number

国药准字H20080294

Company重庆康刻尔制药股份有限公司

Registration Date

January 3, 2023

Previous Approval Numbers

国药准字H20080294

Drug Information

Generic Name

氯雷他定口腔崩解片

Trade Name

伉尔纾坦

Brand Name

伉尔纾坦

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

January 3, 2023

Company Information

Applicant Company

Company Name重庆康刻尔制药股份有限公司

Company Address

重庆市北部新区经开园金渝大道101号

Manufacturing Company

Company Name重庆康刻尔制药股份有限公司

Company Address

重庆市北部新区经开园金渝大道101号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

氯雷他定口腔崩解片 - NMPA 批准文号 | MedPath